In animal and cellular models of AD, the expression of miR-200a-3p was suppressed, and miR-200a-3p treatment inhibited apoptosis, inactivated Bax/caspase-3 axis and phosphorylated tau protein [75]. Here, MAPT is linked to Alzheimer disease.